Document Code: SCF-AMC-STRANDSHIFT-EPC-0001

Program: PROJECT STRANDSHIFT

Classification: Etiopathogenesis Intelligence Core

Objective: Identify and characterize inherited, acquired, inflammatory, viral-response, neuroimmune, epigenomic, and DNA-injury mechanisms contributing to Huntington's disease pathogenesis and progression.

EXECUTIVE SUMMARY

The Etiopathogenic Core represents the foundational disease-origin model for PROJECT STRANDSHIFT.

The purpose is to reconstruct the complete origin architecture of Huntington's disease (HD) and related HTT-associated disorders by identifying the interaction between:

• Inherited genetic susceptibility
• Somatic genomic evolution
• DNA repair dysfunction
• Neurodevelopmental programming
• Neuroimmune activation
• Inflammatory biology
• Endogenous retroelement activation
• Viral-response pathways
• Apoptotic mechanisms
• Environmental and acquired modifiers

The model recognizes Huntington's disease as an inherited monogenic disorder whose progression is modified by multiple convergent biological systems.

ETIOPATHOGENIC CORE ARCHITECTURE

PRIMARY ETIOLOGIC DRIVER

Tier 1 — Inherited Origin

Disease-Causing Event

Pathogenic expansion of CAG trinucleotide repeats within the HTT gene.

Location:

• Chromosome 4p16.3

Result:

• Expanded polyglutamine tract
• Mutant huntingtin protein
• Protein misfolding
• Toxic gain-of-function biology

Classification:

Primary Etiopathogenic Driver

Confidence Level:

Very High

INHERITED ORIGIN MODULE

Genetic Origin Architecture

Core Disease Gene

HTT

Primary Function:

• Vesicular trafficking
• Cytoskeletal regulation
• Synaptic maintenance
• Embryonic development
• Neuroprotection

Pathogenic State:

• CAG repeat expansion

Consequences:

• Protein aggregation
• Transcriptional dysregulation
• Synaptic dysfunction
• Cellular stress

Genetic Modifier Network

DNA Repair Modifiers

MSH3

Role:

Mismatch repair

Etiopathogenic Contribution:

Accelerates somatic repeat expansion

Classification:

Disease Progression Modifier

FAN1

Role:

DNA damage repair

Contribution:

Suppresses repeat expansion

Classification:

Protective Modifier

MLH1

PMS1

PMS2

MSH2

EXO1

Contribution:

Expansion dynamics modulation

Classification:

Genomic Stability Regulators

ACQUIRED ORIGIN MODULE

Somatic Expansion Etiology

Core Mechanism

Inherited HTT mutation undergoes progressive expansion throughout life.

Process:

Inherited CAG Repeat

↓

DNA Replication Stress

↓

Repair Error Accumulation

↓

Somatic Expansion

↓

Cellular Toxicity

↓

Neurodegeneration

Classification:

Acquired Genomic Amplification Process

Confidence:

High

Environmental Modifier Layer

Potential Contributors:

• Chronic inflammation
• Oxidative stress
• Mitochondrial dysfunction
• Metabolic dysregulation
• Aging

Role:

Disease acceleration rather than disease initiation.

Classification:

Secondary Etiopathogenic Modifiers

DNA-INJURY ORIGIN MODULE

Genomic Instability Pathway

Primary Mechanisms

DNA Double-Strand Breaks

Effects:

• Repair pathway activation
• Repeat instability
• Cellular stress

Replication Stress

Effects:

• DNA polymerase stalling
• Repeat expansion susceptibility

Oxidative DNA Damage

Biomarkers:

• 8-OHdG
• γH2AX

Effects:

• Mutation burden
• Repair pathway overload

DNA Repair Failure Axis

Primary Systems:

• ATM
• ATR
• PARP1
• BRCA1
• BRCA2
• FAN1
• MSH3

Etiopathogenic Role:

Progressive amplification of genomic instability.

Classification:

Secondary Disease Driver

INFLAMMATORY ORIGIN MODULE

Neuroimmune Activation

Early Disease Component

Activated Systems:

• Microglia
• Astrocytes
• Complement cascade

Biomarkers:

• IL-1β
• IL-6
• TNF-α
• CXCL10
• CCL2

Effects:

• Synaptic dysfunction
• Neuronal injury
• Disease amplification

Classification:

Inflammatory Disease Accelerator

Chronic Inflammation Loop

Mutant HTT

↓

Cellular Stress

↓

Immune Activation

↓

Inflammatory Cytokines

↓

Neuronal Injury

↓

Further Immune Activation

Classification:

Self-Reinforcing Pathogenic Loop

VIRAL-RESPONSE ORIGIN MODULE

Scientific Position

No evidence currently supports conversion of damaged HTT DNA into infectious viruses.

PROJECT STRANDSHIFT therefore distinguishes:

A. Exogenous Viral Infection

Actual viral pathogens.

Examples:

• HSV-1
• HSV-2
• EBV
• CMV
• HHV-6

Classification:

External Biological Exposure

B. Endogenous Retroelement Activation

Examples:

• HERV-K
• HERV-W
• LINE-1

Potential Triggers:

• DNA injury
• Epigenetic dysregulation
• Neuroinflammation

Classification:

Endogenous Genome Reactivation

C. Viral Mimicry Biology

Characteristics:

• Interferon activation
• dsRNA sensing
• Antiviral signaling

Without active infection.

Classification:

Pseudo-Viral Cellular State

AUTOIMMUNE CONVERGENCE MODULE

Shared Biological Architecture

Shared Systems:

• Interferon signaling
• NF-κB activation
• Cytokine production
• Innate immune activation

Potential Shared Nodes:

• JAK-STAT
• IRF pathways
• cGAS-STING

Role:

Amplification of tissue injury

Classification:

Convergent Pathogenic Network

APOPTOSIS ORIGIN MODULE

Cell Fate Dysregulation

Primary Drivers:

• DNA damage
• Protein aggregation
• Mitochondrial dysfunction
• Neuroinflammation

Systems:

• TP53
• CASP3
• CASP7
• CASP9
• BAX
• BCL2

Effects:

• Neuronal loss
• Tissue degeneration

Classification:

Terminal Pathogenic Execution System

NEURODEVELOPMENTAL ORIGIN MODULE

Developmental Vulnerability Architecture

Potential Contributors:

Prenatal Factors

• Maternal stress
• Inflammatory exposure
• Nutritional factors

Early-Life Factors

• Cognitive reserve development
• Synaptic maturation
• Stress adaptation

Role:

Influence disease resilience and age of symptom manifestation.

Classification:

Disease-Modifying Developmental Layer

SCF ETIOPATHOGENIC CONVERGENCE MODEL

Tier 1 — Disease Initiation

• HTT CAG expansion

Tier 2 — Genomic Amplification

• Somatic expansion
• DNA repair dysfunction

Tier 3 — Cellular Toxicity

• Protein misfolding
• Aggregate formation
• Mitochondrial dysfunction

Tier 4 — Neuroimmune Activation

• Microglial activation
• Cytokine amplification

Tier 5 — Viral Mimicry & Retroelement Activation

• HERV activation
• Interferon signaling
• dsRNA sensing

Tier 6 — Apoptotic Execution

• Caspase activation
• Neuronal death

Tier 7 — Clinical Disease Expression

• Motor dysfunction
• Cognitive impairment
• Psychiatric manifestations

ETIOPATHOGENIC CORE CONCLUSIONS

Primary Disease Origin

Inherited HTT CAG repeat expansion.

Secondary Disease Drivers

• Somatic repeat expansion
• DNA repair dysfunction
• Genomic instability

Amplification Systems

• Neuroimmune activation
• Chronic inflammation
• Mitochondrial dysfunction

Viral-Response Components

• Viral mimicry pathways
• Endogenous retroelement activation

Terminal Execution Systems

• Apoptosis
• Neurodegeneration

Integrated Disease Model

Huntington's disease is best characterized as a genetically initiated, genomically amplified, neuroimmune-modulated, and apoptosis-mediated neurodegenerative disorder whose progression emerges from the convergence of inherited mutation, acquired genomic instability, inflammatory signaling, and cellular stress-response systems.

MASTER REGISTRY INDEX

SCF-AMC-STRANDSHIFT-EPC-0001 — Etiopathogenic Core Report

SCF-AMC-STRANDSHIFT-ODM-0001 — Disease Origin Model

SCF-AMC-STRANDSHIFT-GIA-0001 — Genomic Instability Atlas

SCF-AMC-STRANDSHIFT-DRF-0001 — DNA Repair Failure Atlas

SCF-AMC-STRANDSHIFT-NIA-0001 — Neuroimmune Intelligence Atlas

SCF-AMC-STRANDSHIFT-VIM-0001 — Viragenesis Intelligence Map

SCF-AMC-STRANDSHIFT-ACA-0001 — Autoimmune Convergence Atlas

SCF-AMC-STRANDSHIFT-AEA-0001 — Apoptotic Execution Atlas

SCF-PATH-UT-0001 — SCF Pathophysiology Protocol

SCF-DMRD-MASTER-0001 — SCF Advanced Disease Modeling & Discovery